Opioids Drugs Market- Global Industry Trends, Size, Share and Analytics 2019-2027

1
GLOBAL OPIOIDS DRUG MARKET
FORECAST 2019-2027
2
(No Transcript)
3

• The global opioids drugs market is anticipated to
  grow at a CAGR of 2.52 between 2019 and 2027.
• Opioids are narcotic drugs and mostly directed
  for pain management. Increasing case of road
  accidents surgical procedures are the main
  drivers that are propagating the global market
  growth for opioids drugs.

4

• The opioid drugs are commonly used for
  alleviating the post-operative pains caused by
  surgical procedures.
• Opioid drugs are approved by FDA in the United
  States with ADF labeling and are currently
  marketed in North America.
• The market is segmented by products and
  applications, out of which, the formers
  oxycodone sub-segment is estimated to hold the
  highest market share in 2018.
• Growing demand for palliative care that aims to
  improve the quality of life for the patient
  suffering from terminal illness by implementing
  the use of opioid drugs is further driving the
  said markets growth.
• The growing opioid addiction crisis is leading to
  submission of lawsuits against pharmaceuticals
  companies who are manufacturing the opioid drugs.

5
(No Transcript)
6
The global opioids drugs market is anticipated
to grow at a CAGR of 2.52 between 2019 and 2027.
7
The North America opioids drug market is expected
to contribute the majority of share X by 2027.
Also, the market is growing steadily at 2.29
CAGR during the forecast tenure of 2019-2027.
8
Europe accounts for a significant share of the
global market of opioid drugs, accounting for
approximately X in 2018 and is apprehended to
proliferate at a CAGR of 2.49 to reach XX
billion in revenue by 2027.
9
The Asia Pacific opioids drug market growth has
been quantified to be 3.06 during the forecast
period 2019-2027.
10
Acura Pharmaceuticals, Inc., Allergan PLC,
BioDelivery Sciences International, Inc., Cipher
Pharmaceuticals, Inc., Collegium Pharmaceutical,
Inc., Daiichi Sankyo, Inc., Egalet Corp., Hikma
Pharmaceuticals PLC, Indivior, Inc., Insys
Therapeutics, Inc., Janssen Pharmaceuticals,
Inc., Johnson Johnson, Lannett Co. Inc., Lupin
Ltd., Mylan NV, Pfizer, Inc., Purdue Pharma LP,
Sanofi-Aventis S.A., Sun Pharmaceutical
Industries Limited (Sun Pharma) and Teva
Pharmaceutical Industries Ltd. are some of the
key market players who are dominating the global
opioids market.
11
(No Transcript)
12
(No Transcript)
13
(No Transcript)